Previous studies on SNAI1 and/or TWIST1 in EC mostly relied on their immunohistochemical evaluation in tumor cells in the context of clinical variables, and increased SNAI1 and TWIST1 expression has been linked to EC progression or poor prognosis [23,24,25,26]. The gene discussed is SNAI1; the disease is neoplasm.